[RCUS] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[RCUS] Arcus Biosciences, Inc.
Announcement Date
24-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- -53.66%
Quarter Report
RCUS's Result
RCUS's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 117,000 112,000 382,882 77,517 15,000 8,353 1,413 108.70%
PBT -301,000 -266,000 54,645 -122,858 -84,710 -49,594 -53,082 33.51%
Tax 6,000 1,000 1,815 -6,181 -8,779 5,265 0 -
NP -307,000 -267,000 53,000 -116,677 -75,931 -49,594 -53,082 33.95%
Tax Rate - - -3.32% - - - - -
Total Cost 424,000 379,000 329,882 194,194 90,931 57,947 54,495 40.74%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -262.39 -238.39 13.84 -150.52 -506.21 -593.73 -3,756.69 -35.81%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -4.15 -3.71 0.76 -2.13 -1.73 -1.43 -1.25 22.12%
EPS Diluted -4.15 -3.71 0.71 -2.13 -1.73 -1.43 -1.25 22.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.